Profile data is unavailable for this security.
About the company
Active Biotech AB (publ) is a Sweden-based Company, which develops pharmaceutical products within medical areas where the immune defense is important, including cancer and inflammatory diseases. The project portfolio comprises both small, orally active immunomodulatory molecules and antibody-based immunotherapy.
- Revenue in SEK (TTM)0.00
- Net income in SEK-45.80m
- Incorporated1983
- Employees11.00
- LocationActive Biotech AB publScheelevagen 22LUND 223 63SwedenSWE
- Phone+46 46192000
- Fax+46 46191105
- Websitehttps://www.activebiotech.com/
More ▼
Peer analysis
Key Information
- Key Information
- Stock Performance
- Per Share Data
- Efficiency
- Management Effectiveness
- Profitability
- Financial Strength
- Growth Rates
| Company | Revenue (TTM) | Net income (TTM) | Market cap | Employees | Price/earnings (TTM) | Price/book value (MRQ) | Price/cash flow (TTM) | Price/sales (TTM) | EPS (excl. extraordinary items, TTM) | EPS (incl. extraordinary items, TTM) | Revenue per share (TTM) | Book value per share (MRQ) | Asset turnover (TTM) | Inventory turnover (TTM) | Receivables turnover (TTM) | Revenues per employee (TTM) | Return on avg assets (TTM) | Return on avg assets (5 yr avg) | Return on investment (TTM) | Return on investment (5 yr avg) | Gross margin (TTM) | Gross margin (5 yr avg) | Net profit margin (TTM) | Net Profit margin (5 yr avg) | Quick ratio (MRQ) | Interest coverage (TTM) | Total debt to capital (MRQ) | Payout ratio (5 yr avg) | Revenue (YOY change %) | Revenue (5 yr growth rate) | Net income (YOY change %) | Net income (5 yr growth rate) | Capital expenditure (5 yr growth rate) | Dividend (5 yr growth rate) |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Vo2 Cap Holding AB (publ) | 344.97m | 5.56m | 150.28m | -- | 26.99 | 0.6688 | 4.01 | 0.4356 | 0.1041 | 0.1041 | 6.53 | 4.20 | 0.7076 | -- | 5.39 | -- | 1.14 | -0.2564 | 1.58 | -0.3839 | 34.78 | 23.36 | 1.61 | -0.2409 | -- | 6.13 | 0.1628 | -- | -26.09 | 85.65 | -57.92 | -- | -17.96 | -- |
| PMD Device Solutions AB | 10.21m | -28.81m | 152.19m | 1.00 | -- | -- | -- | 14.91 | -60.60 | -60.60 | 21.39 | -204.84 | 0.3345 | -- | 4.93 | -- | -94.42 | -- | -- | -- | -29.08 | -- | -282.27 | -- | 0.0568 | -6.50 | -- | -- | -- | -- | -- | -- | -- | -- |
| Xintela AB | 78.00k | -54.09m | 154.23m | -- | -- | 35.21 | -- | 1,977.25 | -0.1524 | -0.1524 | 0.0002 | 0.0077 | 0.0036 | -- | 0.0088 | -- | -252.09 | -181.06 | -1,065.04 | -391.61 | 100.00 | -- | -69,343.59 | -235,894.00 | -- | -50.47 | 0.00 | -- | -- | -45.54 | 18.32 | -- | -61.47 | -- |
| AlzeCure Pharma AB | 0.00 | -37.43m | 162.98m | 11.00 | -- | 8.25 | -- | -- | -0.5685 | -0.5685 | 0.00 | 0.2122 | 0.00 | -- | -- | 0.00 | -92.80 | -52.78 | -115.25 | -57.01 | -- | -- | -- | -- | -- | -- | 0.00 | -- | -- | -- | 33.91 | -- | -- | -- |
| Enorama Pharma AB | 1.22m | -43.96m | 163.53m | -- | -- | 6.87 | -- | 134.26 | -2.16 | -2.16 | 0.0423 | 0.4309 | 0.0306 | 1.07 | 0.3212 | -- | -110.45 | -64.94 | -277.27 | -94.45 | -267.08 | 86.49 | -3,609.52 | -405.42 | 0.7249 | -- | 0.023 | -- | -37.96 | 34.20 | -51.50 | -- | -- | -- |
| Vivesto AB | 0.00 | -128.74m | 164.64m | 14.00 | -- | 0.8324 | -- | -- | -0.2414 | -0.2414 | 0.00 | 0.3676 | 0.00 | -- | -- | 0.00 | -44.66 | -- | -48.73 | -- | -- | -- | -- | -- | -- | -- | 0.00 | -- | -100.00 | -- | 64.80 | -- | -- | -- |
| Kancera AB | 0.00 | -64.89m | 184.45m | 3.00 | -- | -- | -- | -- | -0.786 | -0.786 | 0.00 | -- | -- | -- | -- | 0.00 | -- | -54.82 | -- | -66.21 | -- | -- | -- | -7,249.06 | -- | -- | -- | -- | -- | -- | -23.64 | -- | -- | -- |
| SenzaGen AB | 49.87m | -22.10m | 193.51m | 34.00 | -- | 2.86 | -- | 3.88 | -0.9136 | -0.9136 | 2.06 | 2.80 | 0.4594 | 3.04 | 4.03 | 1,466,765.00 | -20.35 | -25.84 | -27.59 | -29.85 | 70.05 | 68.62 | -44.31 | -132.29 | 1.22 | -- | 0.0242 | -- | 19.39 | 90.32 | 11.30 | -- | -21.10 | -- |
| Active Biotech AB publ | 0.00 | -45.80m | 195.34m | 11.00 | -- | 6.37 | -- | -- | -0.172 | -0.172 | 0.00 | 0.0848 | 0.00 | -- | -- | -- | -96.37 | -57.97 | -126.15 | -97.83 | -- | -- | -- | -1,454.61 | -- | -- | 0.1291 | -- | -- | -- | 21.54 | -- | -- | -- |
| Saniona AB | 16.84m | -95.81m | 202.23m | 23.00 | -- | -- | -- | 12.01 | -1.28 | -1.28 | 0.226 | -0.2895 | 0.1546 | -- | 4.71 | 732,173.90 | -87.96 | -59.16 | -108.11 | -70.15 | -213.08 | -970.05 | -568.94 | -1,483.55 | -- | -3.18 | 1.44 | -- | 10.19 | -21.05 | 54.71 | -- | -34.94 | -- |
| InDex Pharmaceuticals Holding AB | 108.34m | -56.48m | 206.15m | 7.00 | -- | 0.8736 | -- | 1.90 | -0.1037 | -0.1037 | 0.2028 | 0.443 | 0.3559 | -- | -- | 15,477,000.00 | -18.55 | -37.64 | -21.24 | -41.14 | -46.98 | -450.51 | -52.13 | -454.62 | -- | -- | 0.0086 | -- | -- | 277.02 | 5.05 | -- | -- | -- |
| Exact Therapeutics AS | 0.00 | -48.07m | 215.35m | 8.00 | -- | 4.80 | -- | -- | -1.51 | -1.51 | 0.00 | 1.41 | 0.00 | -- | -- | -- | -67.21 | -40.21 | -86.14 | -45.67 | -- | -- | -- | -- | -- | -16,578.57 | 0.0258 | -- | -- | -- | -20.52 | -- | -- | -- |
| Corline Biomedical AB | 25.03m | -1.81m | 224.58m | 13.00 | -- | 2.41 | -- | 8.97 | -0.0841 | -0.0841 | 1.16 | 4.34 | 0.248 | -- | 10.92 | 1,925,385.00 | -1.79 | -5.71 | -1.92 | -6.24 | 113.38 | 128.60 | -7.22 | -38.46 | -- | -89.40 | 0.00 | -- | 6.28 | 74.14 | -177.67 | -- | 62.51 | -- |
| Abliva AB | 137.00k | -95.51m | 225.05m | 6.00 | -- | 2.50 | -- | 1,642.70 | -0.0904 | -0.0904 | 0.0001 | 0.067 | 0.001 | -- | 0.0034 | -- | -70.40 | -74.59 | -80.95 | -86.98 | -14,491.24 | -- | -69,714.60 | -65,958.89 | -- | -- | 0.00 | -- | 341.94 | 93.89 | -12.02 | -- | -19.74 | -- |
| SynAct Pharma AB | 0.00 | -215.81m | 236.72m | 5.00 | -- | 1.34 | -- | -- | -6.54 | -6.54 | 0.00 | 4.95 | 0.00 | -- | -- | 0.00 | -116.46 | -125.17 | -130.53 | -151.70 | -- | -- | -- | -- | -- | -- | 0.0036 | -- | -- | -- | -117.54 | -- | -- | -- |
Data as of May 03 2024. Currency figures normalised to Active Biotech AB publ's reporting currency: Swedish Krona SEK
6.41%Per cent of shares held by top holders
| Holder | Shares | % Held |
|---|---|---|
| Fj�rde AP-fondenas of 31 Dec 2023 | 17.05m | 4.50% |
| Handelsbanken Fonder ABas of 31 Mar 2024 | 2.03m | 0.54% |
| Skandia Investment Management ABas of 29 Feb 2024 | 1.84m | 0.49% |
| SEB Investment Management ABas of 28 Mar 2024 | 1.76m | 0.47% |
| FCG Fonder ABas of 30 Jun 2022 | 1.39m | 0.37% |
| Storebrand Asset Management ASas of 31 Jan 2024 | 140.60k | 0.04% |
| Case Kapitalf�rvaltning ABas of 30 Nov 2022 | 64.71k | 0.02% |
| Tredje AP-fondenas of 31 Dec 2021 | 0.00 | 0.00% |
More ▼
Data from 31 Dec 2022 - 31 Mar 2024Source: FactSet Research Systems Inc.
